HIGHLIGHTS
- who: ATAD et al. from the Department of Gynecologic Oncology, Third Affiliated Hospital of Harbin Medical University, Harbin Heilongjiang Province, China have published the Article: ATAD2 Upregulation Promotes Tumor Growth and Angiogenesis in Endometrial Cancer and Is Associated with Its Immune Infiltration, in the Journal: Disease Markers of 28/Nov/2022
- what: This model has been used in recent years in gynecologic oncology to enhance patient survival via collaboration among gynecologists, oncologists, geneticists, and molecular biologists .
- how: In this study Tumor IMmune Estimation Resource (TIMER) was used for ATAD2-associated pan-cancer analysis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.